PATIENT ALERT: Virginia Oncology Associates now requires all patients and visitors to complete our online pre-COVID screening 72 hours prior to your appointment. Please CLICK HERE to complete the questionnaire.  Masks are still required in all offices.   Information regarding COVID-19.  

Mindfulness, Meditation, and Yoga Benefits for Cancer Patients

March 30, 2022

By: Jennifer Cashwell, MSN, FNP-BC

With the increasing success of cancer treatments and the ability to return to previous family, social, and work activities, symptom management and quality of life are essential for cancer survivorship. Mindfulness, meditation, and yoga have consistently shown benefits to cancer patients and survivors. They can decrease unpleasant side effects of cancer treatment, such as nausea and vomiting, reduce stress, increase a feeling of calm, improve mood and sleep quality, and increase mental acuity.

Read More Categories: Cancer Management

Significant Shifts in the Management of Prostate Cancer

March 4, 2022

Detection, understanding, and treatment of prostate cancer have evolved rapidly in recent years. These discoveries have offered prostate cancer patients new hope and a need for a more multidisciplinary approach to care. 

Read More Categories: Prostate Cancer

Take Steps to Prevent Cancer and Detect it Early for the Best Outcomes

February 22, 2022

Age is a Common Risk Factor for Cancer

If you don’t want cancer, don’t get old.

The National Cancer Institute, the Centers for Disease Control and Prevention (CDC), the Dana Farber Cancer Institute, and many other trustworthy organizations say aging is the number one risk factor for getting a cancer diagnosis. While cancer can develop at any age, the incidence of cancer climbs as we age, with the median age of diagnosis at 66 years, according to the NCI.

Read More Categories: Cancer Prevention

What is MGUS and Why Is It Important to Monitor for It?

December 21, 2021

By: Bo Zhao, MD, PhD

Monoclonal gammopathy is a medical condition caused by abnormal proteins in the blood. These proteins grow from a small number of plasma cells, a type of white blood cell, found in the bone marrow. The most common condition linked with these abnormal proteins is monoclonal gammopathy of undetermined significance (MGUS). It is not cancer but does put these patients in a higher risk category for developing cancer in the blood or bone marrow.

Read More Categories: Cancer Research, Blood Cancer

Clinical Trials Driving Improved Survival Rates in Triple-Negative Breast Cancer

August 31, 2021

By: Michael A. Danso, MD

The advent of immunotherapy and genomic analyses of cancer cells has led to rapid evolution in treatment options for patients with triple-negative breast cancer (TNBC). 

Recent and ongoing clinical trials have identified multiple therapies that may help cure more early-stage patients with this often-aggressive cancer, a form prevalent in both younger women and African Americans. 

Read More Categories: Breast Cancer, Cancer Research

A New Treatment Approach for Triple-Negative Breast Cancer

July 28, 2021

By: Sonia E. Hepburn, MD

Until recently, breast cancer has remained largely in the background as immunotherapy has gained ground in treating many other types of cancer.

However, evidence now supports a combination of immunotherapy and chemotherapy as a first-line treatment for patients with metastatic triple-negative breast cancer (TNBC), an aggressive form of breast cancer.

Read More Categories: Breast Cancer, Cancer Research, Cancer Treatment

FAQs from Cancer Patients About the Coronavirus Vaccine

July 26, 2021

By: Jennifer Cashwell, MSN, FNP-BC

We receive a lot of very good questions about COVID vaccinations for cancer patients and patients with other hematologic conditions. Here you'll find a collection of commonly asked questions and the answers from our cancer specialists.

Read More Categories: Coronavirus

How Breast Cancer Treatment Has Become More Conservative and Effective

July 23, 2021

By: Kasey Fuqua

Breast Cancer Treatment Has Become More Tailored and Targeted

Treatment for breast cancer has come a long way from mastectomies and broad-spectrum chemotherapy. Thanks to new research and clinical trials, treatment has become more personalized—and conservative—than ever, improving not only survival rates but quality of life throughout survival. For the nearly 235,000 people diagnosed with breast cancer in the United States each year, these advances can’t come soon enough.

Read More Categories: Breast Cancer, Genetic Testing, Cancer Research

VOA Selected as one of 10 Sites for New Clinical Trial MYLUNG

July 9, 2021

By J. Christopher Paschold, MD, FACP

Virginia Oncology Associates (VOA) was recently selected as one of only ten sites in the country to be part of a collaborative that includes McKesson and life science companies participating in a clinical research study called MYLUNG. MYLUNG stands for Molecularly Informed Lung Cancer Treatment in a Community Cancer Network: A Pragmatic Consortium. The work of this consortium, which will eventually involve more than 12,000 patients, is to better understand metastatic non-small cell lung cancer at the molecular level and develop more targeted treatment plans.

Read More Categories: Lung Cancer, Cancer Research

8 Facts You Probably Didn't Know About Prostate Cancer

May 10, 2021

Prostate cancer is typically a slow-growing type of cancer that has a rate of high survival when found early. That’s why it's important to learn more about it, including some of the more surprising facts about this type of cancer. The more you know, the more likely you’ll be to notice when something is different and get checked out by your doctor. 

Here, we've put together a list of some of the lesser-known facts about prostate cancer.

Read More Categories: Prostate Cancer

1 2 3 4 5